Facebook
Twitter
LinkedIn
Forward
Emerging Technologies for the Management of Colon Cancer
SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 60 Minutes
Overview
Colon cancer is the 3rd most common cancer in the US and ranks 2nd as the cause of cancer-related deaths overall. Participants will improve their understanding of how tumor profiles and biomarker analysis can assist in selecting targeted therapies for patients with colon cancer. Experts will also discuss the evidence available for circulating tumor DNA assays and they can detect minimal residual disease in colorectal cancer patients.
Target Audience
This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.
Learning Objectives
1. Describe how to use tumor profile, biomarker analysis, and patient-specific characteristics to select targeted therapies for individuals with colon cancer
2. Review the evidence for use of circulating tumor (ct) DNA assays in detecting minimal residual disease in patients with colorectal cancer
Faculty
Nancy Wipf, DNP, MSN, MEd, FNP-BC, AOCNP
Dr. Nancy Wipf graduated from University of Texas Pan-American with her Bachelor of Science in Nursing in 1998, and later obtained a Master of Science in Nursing in 2003. In 2018, she obtained a post Master’s in Nursing Education as she is a life-long learner who utilizes evidence-based practices and a variety of learning styles to meet the oncology educational and practice needs of current and future advanced care providers. Last year, she completed her Doctor of Nursing Practice degree from the University of Texas at Arlington. She joined MD Anderson Cancer Center in 2010 working in the Radiation Oncology Department. She then worked as an APRN in Breast Surgery for 10 years; and in 2021, she was promoted to Supervisor for the Colon & Rectal Surgery Department where she leads an exceptional team of 14 Advanced Practice Providers across all MD Anderson campuses facilitating Inpatient, OR, and Outpatient clinical operations. She has a unique dedication to expediting patient access, quality, safety, enhancing system workflow processes, supporting the professional development of nurses, and education which reflect many of MD Anderson's core values.
Dr. Wipf has also received numerous awards and recognitions. In 2022, she was a finalist for the Brown Nursing Award for Leadership Excellence. She also received the Alice Judkins Professional Development Grant Award in 2022 and 2023. She has co-authored numerous papers and delivered many presentations on breast and colorectal cancers at local, state, national, and international seminars and conferences.
Disclosures:
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.
All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.
Nancy Wipf, DNP, MSN, MEd, FNP-BC, AOCNP discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.
Available Credit
- 0.75 AMA PRA Category 1 Credit™Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.75 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 0.75 credit.
Price
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Complete the post-test and score a minimum of 70%
- Submit the evaluation form
DISCLAIMER:
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Required Hardware/software
Access to the internet is required.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above